Get Your Personalized Supplement StackSupplement Stack Quiz

Organic Ginkgo Leaf Powder

Also known as: Ginkgo, Maidenhair tree, Organic Ginkgo Leaf Powder, EGb 761®, Ginkgo biloba L.

Overview

Ginkgo biloba L., commonly known as Ginkgo or Maidenhair tree, is an ancient tree species whose leaves are used to produce herbal supplements. Organic Ginkgo Leaf Powder is derived from these dried leaves and contains a complex mixture of phytochemicals, including flavonoids, terpenoids (specifically terpene lactones), and organic acids. Standardized extracts, such as EGb 761®, are often preferred due to their consistent composition of active compounds. This supplement is primarily used to support cognitive function, enhance blood circulation, and has been investigated for its potential benefits in conditions like dementia, ischemic stroke, and diabetic kidney disease. Research on Ginkgo biloba is extensive, with numerous clinical trials and meta-analyses exploring its various applications, though the quality and consistency of evidence can vary depending on the specific health indication and extract used.

Benefits

Ginkgo biloba offers several evidence-based benefits, primarily in cognitive function and circulatory health. Meta-analyses indicate that Ginkgo biloba extract can improve cognitive function and daily living activities in dementia patients, showing moderate effect sizes (e.g., SMD = -0.49, p=0.001), although study heterogeneity is noted. For diabetic kidney disease (DKD), a meta-analysis found that Ginkgo biloba extract, when combined with conventional treatments, improved clinical outcomes, with effects varying by patient age and dosage form. In the context of ischemic stroke, systematic reviews suggest that Ginkgo biloba leaf preparations may improve post-stroke clinical outcomes, though consistency across different extracts and study designs is a factor. Preliminary research, including some animal and human studies, points to potential anxiolytic and antidepressant effects, possibly due to its antioxidant properties, but more robust evidence is needed. Limited evidence also suggests it might increase ocular blood flow in glaucoma patients, but direct improvements in vision have not been consistently demonstrated.

How it works

Ginkgo biloba exerts its therapeutic effects through multiple biological pathways, primarily attributed to its flavonoid and terpenoid constituents. These compounds act as potent antioxidants, scavenging free radicals and reducing oxidative stress, which is a key factor in cellular damage and aging. Ginkgo also improves microcirculation and modulates blood flow by reducing platelet aggregation, thereby enhancing oxygen and nutrient delivery to tissues, particularly in the brain. Its active components are believed to influence various neurotransmitter systems, contributing to its cognitive-enhancing properties and neuroprotective effects. Standardized extracts like EGb 761® ensure consistent bioavailability and pharmacological action, making them more reliable for clinical use.

Side effects

Ginkgo biloba is generally well-tolerated when taken at recommended doses. Common side effects, occurring in more than 5% of users, include mild gastrointestinal upset, headaches, and dizziness. Less common side effects (1-5%) may involve allergic skin reactions and palpitations. Rare but serious concerns have emerged from animal studies, where very high doses (≥600 mg/kg) were linked to potential hepatotoxicity and carcinogenicity, including liver tumors and nasal epithelium lesions in rodents. The relevance of these findings to human use at typical supplement doses is uncertain but warrants caution. Ginkgo biloba can interact with medications, particularly anticoagulants and antiplatelet drugs, increasing the risk of bleeding. Therefore, it is contraindicated in individuals with bleeding disorders or those on blood thinners without medical supervision. Safety during pregnancy and lactation has not been well established, and its use in these populations should be avoided.

Dosage

For cognitive benefits, a minimum effective dose of 120 mg/day of a standardized Ginkgo biloba extract is typically recommended. The optimal dosage generally ranges from 120–240 mg/day of a standardized extract, such as EGb 761®, usually divided into two daily doses to maintain steady plasma levels. The maximum safe dose is generally considered to be up to 240 mg/day; higher doses have been associated with adverse effects in animal studies. Standardized extracts are preferred over raw leaf powder due to their consistent active compound profile and predictable efficacy. While no specific cofactors are required, some evidence suggests that fatty meals may enhance the absorption of Ginkgo biloba. It is crucial to adhere to these dosage guidelines to maximize benefits and minimize potential risks.

FAQs

Is organic Ginkgo leaf powder as effective as standardized extracts?

Standardized extracts like EGb 761® have consistent active compound profiles and more clinical evidence. Raw powder may vary significantly in efficacy and active ingredient concentration.

How soon can I expect to see benefits from Ginkgo biloba?

Cognitive and circulatory benefits typically take 4–6 weeks or longer to become noticeable, requiring consistent daily use as recommended.

Is Ginkgo biloba safe for long-term use?

Generally, Ginkgo biloba is considered safe for long-term use at recommended doses, but comprehensive long-term safety data beyond a few years is limited.

Can Ginkgo biloba cause bleeding?

Yes, Ginkgo biloba can increase the risk of bleeding, especially when combined with anticoagulant or antiplatelet medications. Consult a doctor if you are on blood thinners.

Research Sources

https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2024.1408546/full – This meta-analysis of randomized controlled trials investigated the efficacy of Ginkgo biloba extract in diabetic kidney disease (DKD) patients. It concluded that Ginkgo biloba, when combined with conventional treatments, improved clinical outcomes in DKD, with effects influenced by factors like age and dosage form. The study highlights the potential adjunctive role of Ginkgo in managing DKD.
https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.1007746/full – This systematic review and meta-analysis focused on the clinical efficacy of standardized Ginkgo biloba extract (EGb 761®) in patients with ischemic stroke. It found that EGb 761® showed clinical efficacy in improving outcomes post-stroke, though noted variability between different extracts and study designs. The research supports the use of standardized extracts for consistent results.
https://pmc.ncbi.nlm.nih.gov/articles/PMC3679686/ – This systematic review and meta-analysis evaluated the effects of Ginkgo biloba on cognitive function in patients with dementia and schizophrenia. It reported that Ginkgo biloba improved cognitive function and reduced positive symptoms in schizophrenia, with moderate effect sizes. However, the study also noted high heterogeneity among the included trials, suggesting variability in findings.
https://pmc.ncbi.nlm.nih.gov/articles/PMC6373469/ – This review summarized findings from animal toxicity studies on Ginkgo biloba, specifically highlighting observations of liver and nasal tumors in rodents at very high doses (≥600 mg/kg). The study emphasizes that while these doses are significantly higher than typical human consumption, they warrant caution and further investigation into the long-term safety profile of Ginkgo biloba.